Health Care Up Slightly As Growth Stocks Return To Favor -- Health Care Roundup

Health-care companies rose slightly, as investors rotated back into "growth" sectors.

Governments and national health authorities should "stick to the dosing that has been assessed in clinical trials," said U.S. and European pharmaceutical trade groups, in statements responding to recent plans floated in the U.S. and elsewhere to increase supply of vaccines by distributing shots initially reserved as boosters.

 Write to Rob Curran at [e-mail] 

(END) Dow Jones Newswires

01-13-21 1723ET